Project information
CEITEC 2020
(CEITEC2020)
- Project Identification
- LQ1601
- Project Period
- 2/2016 - 12/2020
- Investor / Pogramme / Project type
-
Ministry of Education, Youth and Sports of the CR
- National Feasibility Programme II
- MU Faculty or unit
- Central European Institute of Technology
- Cooperating Organization
-
Institute of Materials Physics of the ASCR, v. v. i.
- Responsible person Doc. Ing. Luboš Náhlík, Ph.D.
- Responsible person Mgr. Vilém Reinöhl, CSc.
- Responsible person prof. MVDr. Jiří Smola, CSc.
- Responsible person prof. Ing. Radimír Vrba, CSc.
- Responsible person doc. MVDr. Martin Anger, CSc.
The subject matter and main goal of this project is to ensure sustainability and further growth of CEITEC through financial support of the research teams assembled during the start-up phase of OP RDI.
The main goal of the project is scientific and research activity and continuous development of the research infrastructure of the Centre of scientific excellence CEITEC for the purpose of further enforcement of competitiveness in life and material sciences. Project is designed to foster synergies between the various scientific disciplines. Cross-fertilization of ideas will see growing advancements in scientific discovery and will stretch the boundaries of conventional discipline-restricted approaches. Mechanisms to encourage these activities will be put in place.
Publications
Total number of publications: 1559
2018
-
Emotion recognition and theory of mind in schizophrenia: A meta-analysis of neuroimaging studies
The World Journal of Biological Psychiatry, year: 2018, volume: 19, edition: Suppl. 3, DOI
-
Energy scale of Dirac electrons in Cd3As2
Physical Review B, year: 2018, volume: 97, edition: 11, DOI
-
Enhanced Ammonia Adsorption on Directly Deposited Nanofibrous Carbon Films
JOURNAL OF SENSORS, year: 2018, volume: 2018, edition: 1, DOI
-
Epigenetic drug screen of rituximab resistant cell line revealed possible treatment targets
Year: 2018, type: Conference abstract
-
Epigenetic drug screen on resistant CLL cells reveals Aurora kinase inhibitors as enhancers of CD20 expression and sensitizers to treatment with CD20 monoclonal antibodies
Year: 2018, type: Conference abstract
-
Epigenetic drug screen on rituximab-resistant cells revealed in unexpected role of Aurora kinase inhibitors in CD20 expression
Year: 2018, type: Conference abstract
-
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation
Leukemia, year: 2018, volume: 32, edition: 5, DOI
-
Evaluation of matrix layer homogeneity utilizing quasi-homogeneous biological tissues in MALDI MSI
Year: 2018, type: Conference abstract
-
Evaluation of the Stability of DNA i-Motifs in the Nuclei of Living Mammalian Cells
Angewandte Chemie International Edition, year: 2018, volume: 57, edition: 8, DOI
-
Evolution of genomic abnormalities during CLL disease course is associated with telomere length changes
Year: 2018, type: Conference abstract